Henry Meds vs Alan Meds: Models, Pricing, Compounding

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The PlexusDx Education Hub helps readers compare GLP-1 telehealth brands and understand the genetics that sit beneath every plan. Browse all Peptides & GLP-1 education

This is an independent editorial comparison. PlexusDx has no commercial relationship with Henry Meds, Alan Meds, or their parent companies, and no affiliate links or compensation are involved.

Full head-to-head: PlexusDx vs Henry Meds →

Henry Meds and Alan Meds both operate in a crowded GLP-1 telehealth field, and a head-to-head query deserves an even-handed answer. This editorial sets the two side by side on the axes that actually differ — model, dispensing, and pricing — while noting the one factor neither brand addresses. The wider market holds dozens of options; this piece stays on the two named. As of April 2026.

Two brands, one category

Both Henry Meds and Alan Meds follow the telehealth-plus-pharmacy blueprint: a virtual evaluation leads to a provider prescription, fulfilled through brand-name FDA-approved dispensing or a compounded GLP-1 preparation via licensed pharmacy pathways. See Henry Meds' official website and Alan Meds' own site for current, brand-specific program details, which shift over time.

Where the models diverge

Because the outline is shared, the meaningful contrasts live in execution: provider type, whether a plan leans on brand-name or compounded product, subscription design, and how present follow-up support feels. Neither brand alters the pharmacology — that comes from the compound. What each controls is the wrapper around it: access, oversight, and how the plan is packaged for you.

Mechanism is set by the compound

Both programs work in the GLP-1 receptor agonist space. GLP-1 receptor agonists such as semaglutide and dual GIP/GLP-1 agonists such as tirzepatide act on appetite regulation, satiety, and gastric emptying. That mechanism is identical no matter which brand prescribes it, which is why comparing Henry Meds and Alan Meds is really a comparison of business models rather than biology.

Pricing without stale numbers

Pricing across GLP-1 telehealth varies widely; as of April 2026 combined monthly totals span roughly $200 to $700 or more once fees, medication, and compounding are included. Both Henry Meds and Alan Meds publish current figures on their own pages. Rather than repeat numbers that may age, confirm each brand's live pricing directly before deciding between them.

The variable neither program measures

Neither Henry Meds nor Alan Meds reads your metabolic genetics. Variants in FTO, GLP1R, MC4R, and TCF7L2 map the appetite and energy-balance biology any GLP-1 compound acts on. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — context, not a response prediction. PlexusDx also offers semaglutide and tirzepatide through its Weight Management Protocols, placing that genetic layer in front of the protocol.

Not affiliated: PlexusDx is not affiliated with Henry Meds or Alan Meds and holds no commercial relationship with the companies compared here.

Related reading on PlexusDx: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

A fair way to close the comparison is to accept that Henry Meds and Alan Meds are more alike than different, and to decide on the margins that matter to you. If provider continuity is your priority, weigh follow-up responsiveness; if budget leads, compare live pricing pages directly; if sourcing is the concern, confirm each brand's dispensing route. The choice is a fit exercise between two comparable programs, not a search for a single right answer. It is worth remembering that both brands can change their offerings, pharmacy partners, and pricing at any time, so a comparison written today is a snapshot rather than a permanent ranking. Re-checking each brand's current pages at the moment you decide protects you from acting on stale details, and keeps the comparison grounded in what each program actually offers now rather than what it offered when an article was written.

Frequently Asked Questions

Is Henry Meds or Alan Meds the better choice?

Neither is objectively superior; both run similar GLP-1 telehealth models. The right fit depends on the specific medication options, pricing tiers, provider type, and follow-up that suit you. Because the underlying pharmacology is identical, the decision comes down to service and cost details published on each brand's own site.

How do Henry Meds and Alan Meds differ on dispensing?

Both can prescribe GLP-1 compounds, but they may differ in whether a plan uses FDA-approved brand product or compounded preparation from a 503A pharmacy, plus subscription structure and provider model. Neither dispensing choice changes the compound's mechanism; it changes sourcing, accountability, and often price. Verify each brand's route before comparing.

Does choosing between them change how well treatment works?

Not biologically. Your response is driven by how your body handles the compound, influenced by metabolic variants like FTO that neither program measures. Choosing a brand affects access, oversight, and cost — not the underlying pharmacology. That is why upstream genetic context can matter more than the brand comparison itself.

How does PlexusDx compare with both brands?

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols and pairs them with the Precision Peptide Genetic Test. The differentiator is pathway-level genetic context mapping FTO, MC4R variants — an upstream layer that Henry Meds, Alan Meds, and most GLP-1 telehealth programs do not provide.

Compare more GLP-1 options in the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.